LCD L36113: MolDX: MGMT Promoter Methylation Analysis — CGS
Policy LCD-L36113 · Oncology
New LCD impacts oncology billing for MGMT analysis.
Code intelligence
C71.0 reimbursement alerts
Policy changes, MAC LCD updates, and CMS guidance matched to code C71.0.
Normal code riskView ICD-10 detail
Signal breakdown
3 shown · 3 total in platform
Risk: Normal
0
Critical
0%
0
High
0%
2
Routine
67%
1
Low
33%
New this month
—
alerts added in last 30 days
Effective soon
—
no upcoming deadlines
Routine
LCD L37001: MolDX: MGMT Promoter Methylation Analysis — WPS
Policy LCD-L37001 · Oncology
New LCD may impact billing for MGMT Promoter test.
LCD L34823: Tumor Treatment Field Therapy (TTFT) — DME MAC
Policy LCD-L34823 · DME
DME MAC LCD for Tumor Treatment Field Therapy coverage & billing rules
Audit documentation
Building an audit file that includes C71.0?
The Tripwire Audit Pack exports 12 months of Oncology policy-change history — every alert with a link to its government source document, as a formatted PDF for compliance distribution plus a machine-readable CSV. Delivered automatically after payment. No account, no call.
Get the Oncology audit pack — $349One-time purchase · not a subscription